Public Comment: Mmgt Thrombotic Risk in Breast Cancer Pts

Management of Thrombotic Risk Associated with Endocrine and Other Systemic Therapy in Patients with Breast Cancer: Guidance from the SSC of the ISTH: Open for public review

The ISTH has recently drafted a guidance manuscript on the management of thrombotic risk associated with endocrine and other systemic therapy in patients with breast cancer, given the accumulating evidence from a comprehensive literature review. The guidance was developed by a panel of 12 content experts.

The draft guidance is available for review HERE. Note: This manuscript is confidential and in draft form.

We now kindly ask the greater community of physicians, scientists, and allied health professionals to review and provide any comments by February 19, 2026.

1. Please enter your information, due to conflict of interest concerns, anonymous comments will not be accepted.
Comments will not be attributed, published or provided to anyone beyond the Guideline and Guidance Committee.

First Name *This question is required.

Last Name *This question is required.

Title

Institution *This question is required.

Country *This question is required.

Email Address *This question is required. This question requires a valid email address.

2. Please indicate any financial or intellectual conflicts of interest you may have related to your comments on this guideline: *This question is required.

3. To which section does your comment apply? *This question is required.

Page, line or figure number:

Comment:

4. To which section does your comment apply? *This question is required.

Page, line or figure number:

Comment:

5. To which section does your comment apply? *This question is required.

Page, line or figure number:

Comment:

6. To which section does your comment apply? *This question is required.

Page, line or figure number:

Comment:

7. To which section does your comment apply? *This question is required.

Page, line or figure number:

Comment:

Click the submit button below to send your comments. If you would like to make additional comments, you may submit additional forms.